Parry Neutraceuticals plans capacity expansionsIllustrative image – not actual.

Parry Neutraceuticals plans to increase the production capacity for Spirulina, which is a single source of all nutrients for a strong immune system, to 300 tonnes. The company also plans to increase the capacity of beta-carotene from 35 tonnes to 75 tonnes by 2003.

 

Presently, the company has a capacity to produce 100 tonnes of Spirulina, which will be increased to 150 tonnes by 2002. The new facility will take the total production capacity for Spirulina to 300 tonnes at an additional cost of Rs.6 crore.

 

The company also plans to introduce more neutraceuticals like antioxidant Astaxanthin for heart and lung care, and essential fatty acid like Omega 3 Fatty acid for brain development.


Among other plans are investment of Rs.5 crore in advertisement and promotional activities and providing neutraceuticals to group company, Parry Confectionery, for candies, biscuits, etc.

← All latest storiesBack to top →